Véronique Becette
ScholarGPS® ID: 25627675494179
Affiliation History
Field
Medicine
Discipline
Pathology
Top Specialties
Cancer | Breast Cancer | Chemotherapy | Neoadjuvant Therapy | Neoplasm | Gene Signature | Microarray | Polymerase Chain Reaction
Metrics Summary
Publication Count
71
Predicted Citations
3,450
Predicted h-index
22
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
1232 Evaluation of HER2 expression in low grade serous carcinoma of the ovary in the antibody-drug conjugate era (conference) ESGO 2024 Congress Abstracts (2024) |
Adaptive nanopore sequencing to determine pathogenicity of BRCA1 exonic duplication (journal article) Journal of Medical Genetics, volume 60, issue 12, pages 1206-1209 (2023). |
APC germline pathogenic variants and epithelial ovarian cancer: causal or coincidental findings? (journal article) Journal of Medical Genetics, volume 60, issue 5, pages 460-463 (2023). |
Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types (journal article) Clinical and Translational Medicine, volume 12, issue 4 (2022). |
Erratum à « Lésions vulvaires précancéreuses. [Gynecol. Obstet. Fertil. Senol. 49 (2021)] (journal article) Gynécologie Obstétrique Fertilité & Sénologie , volume 49, issue 6, pages 567- (2021). |
Lésions vulvaires précancéreuses : mise au point (journal article) Gynécologie Obstétrique Fertilité & Sénologie , volume 49, issue 6, pages 538-546 (2021). |
Co-occurrence of germline BRCA1 and CDH1 pathogenic variants (journal article) Journal of Medical Genetics, volume 58, issue 6, pages 357-361 (2021). |
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological response (journal article) Cancer Imaging, volume 20, issue 1 (2020). |
British Journal of Cancer, volume 122, issue 6, pages 759-765 (2020). |
De Novo ESR1 Hotspot Mutation in a Patient With Endometrial Cancer Treated With an Aromatase Inhibitor (journal article) JCO Precision Oncology (2019). |
Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes (journal article) British Journal of Cancer, volume 120, issue 9, pages 913-921 (2019). |
Journal of Hematology & Oncology, volume 11, issue 1 (2018). |
The iron chelator deferasirox synergises with chemotherapy to treat triple‐negative breast cancers (journal article) The Journal of Pathology, volume 246, issue 1, pages 103-114 (2018). |
The role of neoadjuvant chemotherapy in ovarian cancer (journal article) Expert Review of Anticancer Therapy, volume 18, issue 6, pages 555-566 (2018). |
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma (journal article) Breast Cancer Research and Treatment, volume 169, issue 2, pages 295-304 (2018). |
Revue d'Épidémiologie et de Santé Publique, volume 66 (2018). |
Risk of Serous Endometrial Carcinoma in Women With Pathogenic BRCA1/2 Variant After Risk-Reducing Salpingo-Oophorectomy (journal article) JNCI: Journal of the National Cancer Institute, volume 110, issue 2, pages 213-215 (2018). |
Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer (journal article) Oncotarget, volume 7, issue 51, pages 85124-85141 (2016). |
Cancer, volume 122, issue 19, pages 3032-3040 (2016). |
The Journal of Pathology: Clinical Research, volume 2, issue 4, pages 201-209 (2016). |